{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:20:16Z","timestamp":1791584416742,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brain Health Care"},{"DOI":"10.13039\/100010571","name":"R\u00e9seau en Bio-Imagerie du Quebec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012498","name":"Alzheimer Society Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Healthy Brains for Healthy Lives"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02357-x","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:08:31Z","timestamp":1781179711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Amyloid and tau pathologies are drivers of white matter damage in aging and Alzheimer\u2019s disease"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-3062","authenticated-orcid":false,"given":"Farooq","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Dadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"2357_CR1","doi-asserted-by":"publisher","unstructured":"Josephs KA, Weigand SD, Whitwell JL. Characterizing amyloid-positive individuals with normal Tau PET levels after 5 years: an ADNI study. Neurology [Internet]. 2022 [cited 2025 Sept 8];98. https:\/\/doi.org\/10.1212\/WNL.0000000000200287","DOI":"10.1212\/WNL.0000000000200287"},{"key":"2357_CR2","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1093\/brain\/awad232","volume":"146","author":"LM Aksman","year":"2023","unstructured":"Aksman LM, Oxtoby NP, Scelsi MA, Wijeratne PA, Young AL, Alves IL, et al. A data-driven study of Alzheimer\u2019s disease related amyloid and tau pathology progression. Brain. 2023;146:4935\u201348. https:\/\/doi.org\/10.1093\/brain\/awad232.","journal-title":"Brain"},{"key":"2357_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci. 2020;23:1183\u201393. https:\/\/doi.org\/10.1038\/s41593-020-0687-6.","journal-title":"Nat Neurosci"},{"key":"2357_CR4","doi-asserted-by":"publisher","unstructured":"Kamal F, Morrison C, Maranzano J, Zeighami Y, Dadar M. White matter hyperintensity trajectories in patients with progressive and stable mild cognitive impairment. Neurology. 2023;101:e815\u201324. https:\/\/doi.org\/10.1212\/WNL.0000000000207514.","DOI":"10.1212\/WNL.0000000000207514"},{"key":"2357_CR5","doi-asserted-by":"publisher","unstructured":"Dadar M, Camicioli R, Duchesne S, Collins DL, for the Alzheimer\u2019s Disease Neuroimaging Initiative. The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring [Internet]. 2020 [cited 2025 Sept 8];12. https:\/\/doi.org\/10.1002\/dad2.12091","DOI":"10.1002\/dad2.12091"},{"key":"2357_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2014.07.019","volume":"36","author":"AM Brickman","year":"2015","unstructured":"Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, et al. Reconsidering harbingers of dementia: Progression of parietal lobe white matter hyperintensities predicts Alzheimer\u2019s disease incidence. Neurobiol Aging. 2015;36:27\u201332. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.019.","journal-title":"Neurobiol Aging"},{"key":"2357_CR7","doi-asserted-by":"publisher","unstructured":"Bangen KJ, Thomas KR, Weigand AJ, Sanchez DL, Delano-Wood L, Edmonds EC, et al. Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning. Neurobiology of Aging. Elsevier; 2020;86:134\u201342. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.10.016","DOI":"10.1016\/j.neurobiolaging.2019.10.016"},{"key":"2357_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/jnnp.2003.019273","volume":"75","author":"AA Capizzano","year":"2004","unstructured":"Capizzano AA, Aci\u00f3n L, Bekinschtein T, Furman M, Gomila H, Mart\u00ednes A, et al. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2004;75:822\u20137. https:\/\/doi.org\/10.1136\/jnnp.2003.019273.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2357_CR9","doi-asserted-by":"publisher","unstructured":"Bangen KJ, Preis SR, Delano-Wood L, Wolf PA, Libon DJ, Bondi MW, et al. Baseline white matter hyperintensities and hippocampal volume are associated with conversion from normal cognition to mild cognitive impairment in the framingham offspring study. Alzheimer disease and associated disorders. Lippincott Williams and Wilkins; 2018;32:50\u20136. https:\/\/doi.org\/10.1097\/WAD.0000000000000215.","DOI":"10.1097\/WAD.0000000000000215"},{"key":"2357_CR10","doi-asserted-by":"publisher","unstructured":"Kim S, Choi SH, Lee YM, Kim MJ, Kim YD, Kim JY, et al. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study. International Psychogeriatrics. Cambridge University Press; 2015;27:2069\u201377. https:\/\/doi.org\/10.1017\/S1041610215001076","DOI":"10.1017\/S1041610215001076"},{"key":"2357_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2014-310095","volume":"87","author":"JQ Li","year":"2016","unstructured":"Li JQ, Tan L, Wang HF, Tan MS, Tan L, Xu W, et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease: a systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry. 2016;87:476\u201384. https:\/\/doi.org\/10.1136\/jnnp-2014-310095.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2357_CR12","doi-asserted-by":"publisher","unstructured":"Kamal F, Morrison C, Maranzano J, Zeighami Y, Dadar M. Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD. GeroScience. Springer International Publishing; 2023;45:1\u201316. https:\/\/doi.org\/10.1007\/s11357-022-00665-6","DOI":"10.1007\/s11357-022-00665-6"},{"key":"2357_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1177\/0271678X20957604","volume":"41","author":"L P\u00e5lhaugen","year":"2021","unstructured":"P\u00e5lhaugen L, Sudre CH, Tecelao S, Nakling A, Almdahl IS, Kalheim LF, et al. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns. J Cereb Blood Flow Metab. 2021;41:1162\u201374. https:\/\/doi.org\/10.1177\/0271678X20957604.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2357_CR14","doi-asserted-by":"publisher","unstructured":"Fanlo-Ucar H, Pic\u00f3n-Pag\u00e8s P, Herrera-Fern\u00e1ndez V, ILL-Raga G, Mu\u00f1oz FJ. The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer\u2019s Disease Etiopathology. Antioxidants. 2024;13:1208. https:\/\/doi.org\/10.3390\/antiox13101208","DOI":"10.3390\/antiox13101208"},{"key":"2357_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-024-01417-8","volume":"16","author":"W-J Cha","year":"2024","unstructured":"Cha W-J, Yi D, Ahn H, Byun MS, Chang YY, Choi J-M, et al. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities. Alz Res Therapy. 2024;16:50. https:\/\/doi.org\/10.1186\/s13195-024-01417-8.","journal-title":"Alz Res Therapy"},{"key":"2357_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116944","volume":"218","author":"A Moscoso","year":"2020","unstructured":"Moscoso A, Rey-Bretal D, Silva-Rodr\u00edguez J, Aldrey JM, Cort\u00e9s J, P\u00edas-Peleteiro J, et al. White matter hyperintensities are associated with subthreshold amyloid accumulation. Neuroimage. 2020;218:116944. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.116944.","journal-title":"Neuroimage"},{"key":"2357_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T, et al. Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature. 2023;618:349\u201357. https:\/\/doi.org\/10.1038\/s41586-023-06120-6.","journal-title":"Nature"},{"key":"2357_CR18","doi-asserted-by":"publisher","unstructured":"Strain JF, Smith RX, Beaumont H, Roe CM, Gordon BA, Mishra S, et al. Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions. Neurology [Internet]. 2018 [cited 2025 Sept 10];91. https:\/\/doi.org\/10.1212\/WNL.0000000000005864","DOI":"10.1212\/WNL.0000000000005864"},{"key":"2357_CR19","doi-asserted-by":"publisher","unstructured":"Tian J, Raghavan S, Reid RI, Przybelski SA, Lesnick TG, Gebre RK, et al. White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease. Neurology [Internet]. 2023 [cited 2025 Sept 10];100. https:\/\/doi.org\/10.1212\/WNL.0000000000207250","DOI":"10.1212\/WNL.0000000000207250"},{"key":"2357_CR20","doi-asserted-by":"publisher","unstructured":"the BIOCARD Research Team, Newton P, Tchounguen J, Pettigrew C, Lim C, Lin Z, et al. Regional White Matter Hyperintensities and Alzheimer\u2019s Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment. JAD. 2023;92:323\u201339. https:\/\/doi.org\/10.3233\/JAD-220846","DOI":"10.3233\/JAD-220846"},{"key":"2357_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegeneration. 2019;14:32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5.","journal-title":"Mol Neurodegeneration"},{"key":"2357_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, Schultz C, Sassin I, Tredici KD, Braak E, Braak H. Sequence of Ab-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol. 2000;59:733\u201348.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2357_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z.","journal-title":"Acta Neuropathol"},{"key":"2357_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/alz.12410","volume":"18","author":"A Garnier-Crussard","year":"2022","unstructured":"Garnier-Crussard A, Bougacha S, Wirth M, Dautricourt S, Sherif S, Landeau B, et al. White matter hyperintensity topography in Alzheimer\u2019s disease and links to cognition. Alzheimer\u2019s and Dementia. 2022;18:422\u201333. https:\/\/doi.org\/10.1002\/alz.12410.","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2357_CR25","doi-asserted-by":"publisher","unstructured":"Bucci M, Chiotis K, Nordberg A, for the Alzheimer\u2019s Disease Neuroimaging Initiative. Alzheimer\u2019s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Mol Psychiatry. 2021;26:5888\u201398. https:\/\/doi.org\/10.1038\/s41380-021-01263-2.","DOI":"10.1038\/s41380-021-01263-2"},{"key":"2357_CR26","doi-asserted-by":"publisher","unstructured":"Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, et al. The Alzheimer\u2019s disease neuroimaging initiative 2 PET core: 2015. Alzheimer\u2019s & Dementia. 2015;11:757\u201371. https:\/\/doi.org\/10.1016\/j.jalz.2015.05.001.","DOI":"10.1016\/j.jalz.2015.05.001"},{"key":"2357_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.114.148981","volume":"56","author":"SM Landau","year":"2015","unstructured":"Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, et al. Measurement of longitudinal \u03b2-amyloid change with18 F-florbetapir PET and standardized uptake value ratios. J Nucl Med. 2015;56:567\u201374. https:\/\/doi.org\/10.2967\/jnumed.114.148981.","journal-title":"J Nucl Med"},{"key":"2357_CR28","doi-asserted-by":"publisher","unstructured":"Dadar M, Moqadam R, Metz A, Chadwick K, Brzezinski-Rittner A, Zeighami Y. PELICAN: a longitudinal image processing pipeline for analyzing structural magnetic resonance images in aging and neurodegenerative disease populations. bioRxiv. 2025;2025.09.20.677546. https:\/\/doi.org\/10.1101\/2025.09.20.677546.","DOI":"10.1101\/2025.09.20.677546"},{"key":"2357_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1109\/TMI.2007.906087","volume":"27","author":"P Coupe","year":"2008","unstructured":"Coupe P, Yger P, Prima S, Hellier P, Kervrann C, Barillot C. An optimized blockwise nonlocal means denoising filter for 3-D magnetic resonance images. IEEE Trans Med Imaging. 2008;27:425\u201341. https:\/\/doi.org\/10.1109\/TMI.2007.906087.","journal-title":"IEEE Trans Med Imaging"},{"key":"2357_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/42.668698","volume":"17","author":"JG Sled","year":"1998","unstructured":"Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in mri data. IEEE Trans Med Imaging. 1998;17:87\u201397. https:\/\/doi.org\/10.1109\/42.668698.","journal-title":"IEEE Trans Med Imaging"},{"key":"2357_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroimage.2018.03.025","volume":"174","author":"M Dadar","year":"2018","unstructured":"Dadar M, Fonov VS, Collins DL. A comparison of publicly available linear MRI stereotaxic registration techniques. Neuroimage. 2018;174:191\u2013200. https:\/\/doi.org\/10.1016\/j.neuroimage.2018.03.025.","journal-title":"Neuroimage"},{"key":"2357_CR32","doi-asserted-by":"publisher","unstructured":"Fonov V, Evans AC, Botteron K, Almli CR, McKinstry RC, Collins DL. Unbiased average age-appropriate atlases for pediatric studies. NeuroImage. Elsevier Inc.; 2011;54:313\u201327. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.07.033","DOI":"10.1016\/j.neuroimage.2010.07.033"},{"key":"2357_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroimage.2017.06.009","volume":"157","author":"M Dadar","year":"2017","unstructured":"Dadar M, Maranzano J, Misquitta K, Anor CJ, Fonov VS, Tartaglia MC, et al. Performance comparison of 10 different classification techniques in segmenting white matter hyperintensities in aging. Neuroimage. 2017;157:233\u201349. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.06.009.","journal-title":"Neuroimage"},{"key":"2357_CR34","doi-asserted-by":"publisher","unstructured":"Anor CJ, Dadar M, Collins DL, Tartaglia MC. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer\u2019s Disease and Their Association With White Matter Hyperintensities in the National Alzheimer\u2019s Coordinating Center\u2019s Uniform Data Set. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. Elsevier Inc; 2021;6:70\u20138. https:\/\/doi.org\/10.1016\/j.bpsc.2020.03.006","DOI":"10.1016\/j.bpsc.2020.03.006"},{"key":"2357_CR35","doi-asserted-by":"publisher","unstructured":"Dadar M, Camicioli R, Duchesne S, Collins DL. The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition. Alzheimer\u2019s and Dementia: Diagnosis, Assessment and Disease Monitoring. 2020;12:1\u201311. https:\/\/doi.org\/10.1002\/dad2.12091.","DOI":"10.1002\/dad2.12091"},{"key":"2357_CR36","doi-asserted-by":"publisher","unstructured":"Dadar M, Maranzano J, Ducharme S, Collins DL. White matter in different regions evolves differently during progression to dementia. Neurobiology of Aging. Elsevier; 2019;76:71\u20139. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.12.004.","DOI":"10.1016\/j.neurobiolaging.2018.12.004"},{"key":"2357_CR37","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/hbm.23894","volume":"39","author":"M Dadar","year":"2018","unstructured":"Dadar M, Maranzano J, Ducharme S, Carmichael OT, Decarli C, Collins DL. Validation of T1w-based segmentations of white matter hyperintensity volumes in large-scale datasets of aging. Hum Brain Mapp. 2018;39:1093\u2013107. https:\/\/doi.org\/10.1002\/hbm.23894.","journal-title":"Hum Brain Mapp"},{"key":"2357_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101952","volume":"88","author":"EL Twait","year":"2023","unstructured":"Twait EL, Min B, Beran M, Vonk JMJ, Geerlings MI. The cross-sectional association between amyloid burden and white matter hyperintensities in older adults without cognitive impairment: a systematic review and meta-analysis. Ageing Res Rev. 2023;88:101952. https:\/\/doi.org\/10.1016\/j.arr.2023.101952.","journal-title":"Ageing Res Rev"},{"key":"2357_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2020.03.008","volume":"91","author":"P Walsh","year":"2020","unstructured":"Walsh P, Sudre CH, Fiford CM, Ryan NS, Lashley T, Frost C, et al. CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer\u2019s disease. Neurobiol Aging. 2020;91:5\u201314. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.03.008.","journal-title":"Neurobiol Aging"},{"key":"2357_CR40","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1212\/WNL.0000000000000732","volume":"83","author":"S Thanprasertsuk","year":"2014","unstructured":"Thanprasertsuk S, Martinez-Ramirez S, Pontes-Neto OM, Ni J, Ayres A, Reed A, et al. Posterior white matter disease distribution as a predictor of amyloid angiopathy. Neurology. 2014;83:794\u2013800. https:\/\/doi.org\/10.1212\/WNL.0000000000000732.","journal-title":"Neurology"},{"key":"2357_CR41","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD. The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review. J Nucl Med. 2022;63:13S-19S. https:\/\/doi.org\/10.2967\/jnumed.121.263195.","journal-title":"J Nucl Med"},{"key":"2357_CR42","doi-asserted-by":"publisher","unstructured":"Pascoal TA, Therriault J, Mathotaarachchi S, Kang MS, Shin M, Benedet AL, et al. Topographical distribution of A\u03b2 predicts progression to dementia in A\u03b2 positive mild cognitive impairment. Alzheimer\u2019s & Dementia: diagnosis, assessment & disease monitoring [Internet]. 2020 [cited 2025 Sept 10];12. https:\/\/doi.org\/10.1002\/dad2.12037","DOI":"10.1002\/dad2.12037"},{"key":"2357_CR43","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S, Sch\u00f6ll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, et al. Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017;8:1214. https:\/\/doi.org\/10.1038\/s41467-017-01150-x.","journal-title":"Nat Commun"},{"key":"2357_CR44","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","volume":"85","author":"S Palmqvist","year":"2015","unstructured":"Palmqvist S, Zetterberg H, Mattsson N, Johansson P, Minthon L, Blennow K, et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology. 2015;85:1240\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000001991.","journal-title":"Neurology"},{"key":"2357_CR45","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.2967\/jnumed.123.267150","volume":"65","author":"EE Lecy","year":"2024","unstructured":"Lecy EE, Min H-K, Apgar CJ, Maltais DD, Lundt ES, Albertson SM, et al. Patterns of Early Neocortical Amyloid-\u03b2 Accumulation: A PET Population-Based Study. J Nucl Med. 2024;65:1122\u20138. https:\/\/doi.org\/10.2967\/jnumed.123.267150.","journal-title":"J Nucl Med"},{"key":"2357_CR46","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1093\/brain\/awz162","volume":"142","author":"J Graff-Radford","year":"2019","unstructured":"Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, et al. White matter hyperintensities: relationship to amyloid and tau burden. Brain. 2019;142:2483\u201391. https:\/\/doi.org\/10.1093\/brain\/awz162.","journal-title":"Brain"},{"key":"2357_CR47","doi-asserted-by":"publisher","unstructured":"McAleese KE, Miah M, Graham S, Hadfield GM, Walker L, Johnson M, et al. Frontal white matter lesions in Alzheimer\u2019s disease are associated with both small vessel disease and AD-associated cortical pathology. Acta Neuropathol. 2021;142:937\u201350. https:\/\/doi.org\/10.1007\/s00401-021-02376-2.","DOI":"10.1007\/s00401-021-02376-2"},{"key":"2357_CR48","doi-asserted-by":"publisher","unstructured":"McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, et al. Parietal white matter lesions in Alzheimer\u2019s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathologica. Springer Berlin Heidelberg; 2017;134:459\u201373. https:\/\/doi.org\/10.1007\/s00401-017-1738-2","DOI":"10.1007\/s00401-017-1738-2"},{"key":"2357_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s and Dementia. 2018;14:535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2357_CR50","doi-asserted-by":"publisher","unstructured":"McAleese KE, Firbank M, Dey M, Colloby SJ, Walker L, Johnson M, et al. Cortical tau load is associated with white matter hyperintensities. acta neuropathol commun. 2015;3:60. https:\/\/doi.org\/10.1186\/s40478-015-0240-0","DOI":"10.1186\/s40478-015-0240-0"},{"key":"2357_CR51","doi-asserted-by":"publisher","unstructured":"Garnier-Crussard A, Dadar M, Villain N, Charidimou A, Boulouis G, Cotton F, et al. White matter hyperintensities in Alzheimer\u2019s disease in the era of anti-amyloid therapies. Alzheimer\u2019s Dement. 2026;18:e70349. https:\/\/doi.org\/10.1002\/dad2.70349.","DOI":"10.1002\/dad2.70349"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02357-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:08:32Z","timestamp":1781179712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02357-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":51,"alternative-id":["2357"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02357-x","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all ADNI participants at each participating site, in accordance with ethical guidelines. Our study protocol was approved by the Institutional Review Boards (IRBs) at each center, ensuring adherence to ethical standards and the protection of participant rights.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from participants or their study partner.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no disclosures relevant to the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}